40B — HealthBank Holdings Income Statement
0.000.00%
Last trade - 00:00- SG$8.16m
- SG$7.90m
- CNY0.19m
Annual income statement for HealthBank Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.099 | 0.379 | 0.226 | 0.188 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | -3.69 | 3.96 | 11.6 | 36.3 | 8.41 |
| Operating Profit | 3.69 | -3.86 | -11.2 | -36.1 | -8.22 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.69 | -3.86 | -11.2 | -36.1 | -8.22 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.69 | -3.86 | -11.2 | -36.1 | -8.22 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -4.91 | -3.64 | -11.1 | -36 | -8.17 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.91 | -3.64 | -11.1 | -36 | -8.17 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.13 | -0.047 | -0.144 | -0.382 | -0.087 |